RT Book, Section
A1 Efstathiou, Jason A.
A1 Gray, Phillip J.
A1 Dahl, Douglas M.
A2 Chabner, Bruce A.
A2 Longo, Dan L.
SR Print(0)
ID 1127648570
T1 Localized Prostate Cancers
T2 Harrison's Manual of Oncology, 2e
YR 2016
FD 2016
PB McGraw-Hill Education
PP New York, NY
SN 9780071793254
LK hemonc.mhmedical.com/content.aspx?aid=1127648570
RD 2024/04/24
AB In  the  United  States,  an  estimated  238,590  men  will  be  diagnosed  with  prostate  cancer  in  2013  with  29,720  deaths  attributable  to  prostate  cancer  (1).  These  statistics  highlight  a  paradox  of  prostate  cancer.  Although  it  is  the  second  leading  cause  of  cancer  death  for  men  in  the  United  States,  only  a  relatively  small  percentage  of  men  diagnosed  with  prostate  cancer  will  die  of  their  disease.  This  chapter  will  present  guidelines  for  the  management  of  localized  prostate  cancer.  It  will  describe  the  controversies  associated  with  prostate-specific  antigen  (PSA)  screening,  describe  the  work  up  and  staging  of  prostate  cancer,  and  finally  discuss  treatment  options  for  localized  disease.